Site-Specific Glycoprofiles of HDL-Associated ApoE are Correlated with HDL Functional Capacity and Unaffected by Short-Term Diet

Nov 18, 2019·
Chenghao Zhu
Chenghao Zhu
,
Maurice Wong
,
Qiongyu Li
,
Lisa Sawrey-Kubicek
,
Elizabeth Beals
,
Chris H. Rhodes
,
Romina Sacchi
,
Carlito B. Lebrilla
,
Angela M. Zivkovic
· 0 min read
Abstract
Since high-density lipoprotein (HDL) glycoprofiles are associated with HDL functional capacity, we set out to determine whether diet can alter the glycoprofiles of key HDL-associated proteins, including ApoE, a potent driver of chronic disease risk. Ten healthy subjects consumed a fast food (FF) and a Mediterranean (Med) diet for 4 days in randomized order, with a 4-day wash-out between treatments. A multiple reaction monitoring method was used to characterize the site-specific glycoprofiles of HDL proteins, and HDL functional capacity was analyzed. We describe for the first time that ApoE has 7 mucin-type O-glycosylation sites, which were not affected by short-term diet. The glycoprofiles of other HDL-associated proteins were also unaffected, except that a disialylated ApoC-III glycan was enriched after Med diet, and a nonsialylated ApoC-III glycan was enriched after FF diet. Twenty-five individual glycopeptides were significantly correlated with cholesterol efflux capacity and 21 glycopeptides were correlated with immunomodulatory capacity. Results from this study indicate that the glycoprofiles of HDL-associated proteins including ApoE are correlated with HDL functional capacity but generally unaffected by diet in the short term, except ApoC-III sialylation. These results suggest that HDL protein glycoprofiles are affected by both acute and long-term factors and may be useful for biomarker discovery.
Type
Publication
Journal of Proteome Research
publications
Chenghao Zhu
Authors
Research Assistant Professor
Chenghao Zhu is a Research Assistant Professor in the NCI-designated Cancer Center at Sanford Burnham Prebys. His research focuses on developing computational methods and software for proteogenomics and applying proteogenomics to cancer diagnosis, prognosis, and clinico-epidemiologic questions.